Table 1_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.docx
Introduction<p>The safety concerns of Bruton's tyrosine kinase inhibitors (BTKis) have garnered significant attention due to their severe adverse reactions. However, no existing studies have utilized VigiBase, the world's largest adverse event reporting system, to conduct post-market...
-д хадгалсан:
| Үндсэн зохиолч: | Han Qu (4391905) (author) |
|---|---|
| Бусад зохиолчид: | Yuqi Jia (12074459) (author), Zizhen Liu (10067249) (author), Zuan Li (13285615) (author), Xin Zhao (71840) (author), Zhenghua Wu (548294) (author), Guorong Fan (2294386) (author), Yuefen Lou (11843792) (author) |
| Хэвлэсэн: |
2025
|
| Нөхцлүүд: | |
| Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Table 2_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.xlsx
-н: Han Qu (4391905)
Хэвлэсэн: (2025) -
Table 3_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
-н: Satoko Watanabe (59124)
Хэвлэсэн: (2025) -
Table 2_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
-н: Satoko Watanabe (59124)
Хэвлэсэн: (2025) -
Table 4_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
-н: Satoko Watanabe (59124)
Хэвлэсэн: (2025) -
Table 1_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
-н: Satoko Watanabe (59124)
Хэвлэсэн: (2025)